| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Integrative Physiology |
From Stem Cell Biology (Y.L.T., L.C., J.Z., T.S., M.I.P.), Keck Graduate Institute, Claremont, Calif; and Feinberg Cardiovascular Research Institute (W.Z., M.C., R.K., D.W.L., G.Q.), Northwestern University, Chicago, Ill.
Correspondence to Gangjian Qin, MD, Feinberg Cardiovascular Research Institute, Northwestern University, 303 E Chicago Ave, Tarry 14-751, Chicago, IL 60611. E-mail g-qin{at}northwestern.edu
Myocardial infarction rapidly depletes the endogenous cardiac progenitor cell pool, and the inefficient recruitment of exogenously administered progenitor cells limits the effectiveness of cardiac cell therapy. Recent reports indicate that interactions between the CXC chemokine stromal cell–derived factor 1 and its receptor CXC chemokine receptor 4 (CXCR4) critically mediate the ischemia-induced recruitment of bone marrow–derived circulating stem/progenitor cells, but the expression of CXCR4 in cardiac progenitor cells is very low. Here, we studied the influence of hypoxia on CXCR4 expression in cardiac progenitor cells, on the recruitment of intravenously administered cells to ischemic heart tissue, and on the preservation of heart function in a murine myocardial infarction model. We found that hypoxic preconditioning increased CXCR4 expression in CLK (cardiosphere-derived, Lin–c-kit+ progenitor) cells and markedly augmented CLK cell migration (in vitro) and recruitment (in vivo) to the ischemic myocardium. Four weeks after surgically induced myocardial infarction, infarct size and heart function were significantly better in mice administered hypoxia-preconditioned CLK cells than in mice treated with cells cultured under normoxic conditions. Furthermore, these effects were largely abolished by the addition of a CXCR4 inhibitor, indicating that the benefits of hypoxic preconditioning are mediated by the stromal cell–derived factor 1/CXCR4 axis, and that therapies targeting this axis may enhance cardiac-progenitor cell–based regenerative therapy.
Key Words: cardiac progenitor cells hypoxia CXCR4 cell migration myocardial infarction
Related Article:
Circ. Res. 2009 104: 1133-1135.
This article has been cited by other articles:
![]() |
M. S. Penn, S. Anwaruddin, R. Nair, and S. Ellis From mice to men commonalities in physiology for stem cell-based cardiac repair. J. Am. Coll. Cardiol., December 8, 2009; 54(24): 2287 - 2289. [Full Text] [PDF] |
||||
![]() |
F. H. Seeger, T. Rasper, M. Koyanagi, H. Fox, A. M. Zeiher, and S. Dimmeler CXCR4 Expression Determines Functional Activity of Bone Marrow-Derived Mononuclear Cells for Therapeutic Neovascularization in Acute Ischemia Arterioscler Thromb Vasc Biol, November 1, 2009; 29(11): 1802 - 1809. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Penn Importance of the SDF-1:CXCR4 Axis in Myocardial Repair Circ. Res., May 22, 2009; 104(10): 1133 - 1135. [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2009 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |